{
  "id": "everyday#screening_cues_de81a708",
  "title_en": "General — Screening Cues",
  "title_vi": "General — Dấu hiệu sàng lọc",
  "text_en": "262 Substance-Related and Addictive Disorders 6. Continued sedative, hypnotic, or anxiolytic use despite hav- ing persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of sedatives, hypnot- ics, or anxiolytics (e.g., arguments with a spouse about con- sequences of intoxication; physical fights). 7. Important social, occupational, or recreational activities are given up or reduced because of sedative, hypnotic, or anxio- lytic use. 8. Recurrent sedative, hypnotic, or anxiolytic use in situations in which it is physically hazardous (e.g., driving an automo- bile or operating a machine when impaired by sedative, hyp- notic, or anxiolytic use). 9. Sedative, hypnotic, or anxiolytic use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the sedative, hypnotic, or anxiolytic. 10. Tolerance, as defined by either of the following: a. A need for markedly increased amounts of the sedative, hypnotic, or anxiolytic to achieve intoxication or desired effect. b. A markedly diminished effect with continued use of the same amount of the sedative, hypnotic, or anxiolytic. Note: This criterion is not considered to be met for individu- als taking sedatives, hypnotics, or anxiolytics under medical supervision. 11. Withdrawal, as manifested by either of the following: a. The characteristic withdrawal syndrome for sedatives, hypnotics, or anxiolytics (refer to Criteria A and B of the criteria set for sedative, hypnotic, or anxiolytic withdraw- al, pp. 265–266). b. Sedatives, hypnotics, or anxiolytics (or a closely related substance, such as alcohol) are taken to relieve or avoid withdrawal symptoms. Note: This criterion is not considered to be met for individu- als taking sedatives, hypnotics, or anxiolytics under medical supervision. Sedative, Hypnotic, or Anxiolytic Use Disorder 263 Specify if: In early remission: After full criteria for sedative, hypnotic, or anxiolytic use disorder were previously met, none of the criteria for sedative, hypnotic, or",
  "gloss_vi": "262 substance-related and addictive disorders 6. continued sedative, hypnotic, or anxiolytic use despite hav- ing persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of sedatives...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "screening_cues",
      "referral",
      "do_not_do"
    ],
    "life_topics": [],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Screening Cues General — Dấu hiệu sàng lọc 262 Substance-Related and Addictive Disorders 6. Continued sedative, hypnotic, or anxiolytic use despite hav- ing persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of sedatives, hypnot- ics, or anxiolytics (e.g., arguments with a spouse about con- sequences of intoxication; physical fights). 7. Important social, occupational, or recreational activities are given up or reduced because of sedative, hypnotic, or anxio- lytic use. 8. Recurrent sedative, hypnotic, or anxiolytic use in situations in which it is physically hazardous (e.g., driving an automo- bile or operating a machine when impaired by sedative, hyp- notic, or anxiolytic use). 9. Sedative, hypnotic, or anxiolytic use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the sedative, hypnotic, or anxiolytic. 10. Tolerance, as defined by either of the following: a. A need for markedly increased amounts of the sedative, hypnotic, or anxiolytic to achieve intoxication or desired effect. b. A markedly diminished effect with continued use of the same amount of the sedative, hypnotic, or anxiolytic. Note: This criterion is not considered to be met for individu- als taking sedatives, hypnotics, or anxiolytics under medical supervision. 11. Withdrawal, as manifested by either of the following: a. The characteristic withdrawal syndrome for sedatives, hypnotics, or anxiolytics (refer to Criteria A and B of the criteria set for sedative, hypnotic, or anxiolytic withdraw- al, pp. 265–266). b. Sedatives, hypnotics, or anxiolytics (or a closely related substance, such as alcohol) are taken to relieve or avoid withdrawal symptoms. Note: This criterion is not considered to be met for individu- als taking sedatives, hypnotics, or anxiolytics under medical supervision. Sedative, Hypnotic, or Anxiolytic Use Disorder 263 Specify if: In early remission: After full criteria for sedative, hypnotic, or anxiolytic use disorder were previously met, none of the criteria for sedative, hypnotic, or 262 substance-related and addictive disorders 6. continued sedative, hypnotic, or anxiolytic use despite hav- ing persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of sedatives..."
}